Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care: A Randomized Trial
-
2013/09/11
Details
-
Personal Author:Conrad DA ; Dudley RA ; Hysong SJ ; Petersen LA ; Pietz K ; Profit J ; Simpson K ; Urech TH ; Woodard LD
-
Description:Importance: Pay for performance is intended to align incentives to promote high-quality care, but results have been contradictory. Objective: To test the effect of explicit financial incentives to reward guideline-recommended hypertension care. Design, Setting, and Participants: Cluster randomized trial of 12 Veterans Affairs outpatient clinics with 5 performance periods and a 12-month washout that enrolled 83 primary care physicians and 42 nonphysician personnel (eg, nurses, pharmacists). Interventions: Physician-level (individual) incentives, practice-level incentives, both, or none. Intervention participants received up to 5 payments every 4 months; all participants could access feedback reports. Main Outcomes and Measures: Among a random sample, number of patients achieving guideline-recommended blood pressure thresholds or receiving an appropriate response to uncontrolled blood pressure, number of patients prescribed guideline-recommended medications, and number who developed hypotension. Results: Mean (SD) total payments over the study were $4270 ($459), $2672 ($153), and $1648 ($248) for the combined, individual, and practice-level interventions, respectively. The unadjusted baseline and final percentages and the adjusted absolute change over the study in patients meeting the combined blood pressure/appropriate response measure were 75% to 84% and 8.84% (95% CI, 4.20% to 11.80%) for the individual group, 80% to 85% and 3.70% (95% CI, 0.24% to 7.68%) for the practice-level group, 79% to 88% and 5.54% (95% CI, 1.92% to 9.52%) for the combined group, and 86% to 86% and 0.47% (95% CI, -3.12% to 4.04%) for the control group. The adjusted absolute estimated difference in the change between the proportion of patients with blood pressure control/appropriate response for individual incentive and control groups was 8.36% (95% CI, 2.40% to 13.00%; P=.005). The other incentive groups did not show a significant change compared with controls for this outcome. For medications, the unadjusted baseline and final percentages and the adjusted absolute change were 61% to 73% and 9.07% (95% CI, 4.52% to 13.44%), 56% to 65% and 4.98% (95% CI, 0.64% to 10.08%), 65% to 80% and 7.26% (95% CI, 2.92% to 12.48%), and 63% to 72% and 4.35% (95% CI, -0.28% to 9.28%), respectively. These changes in the use of guideline-recommended medications were not significant in any of the incentive groups compared with controls, nor was the incidence of hypotension. The effect of the incentive was not sustained after a washout. Conclusions and Relevance: Individual financial incentives, but not practice-level or combined incentives, resulted in greater blood pressure control or appropriate response to uncontrolled blood pressure; none of the incentives resulted in greater use of guideline-recommended medications or increased incidence of hypotension compared with controls. Further research is needed on the factors that contributed to these findings. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0098-7484
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:310
-
Issue:10
-
NIOSHTIC Number:nn:20057107
-
Citation:JAMA 2013 Sep; 310(10):1042-1050
-
Contact Point Address:Laura A. Petersen, MD, MPH, Health Services Research and Development (152), Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030
-
Email:laura.petersen@va.gov
-
Federal Fiscal Year:2013
-
Performing Organization:University of Washington
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Journal of the American Medical Association
-
End Date:20250630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:a1952991d48542a6749e7ec4901540b50d34b2aafe821a1bbe588755d1d9f14a0905838759bb79e9d4df90b15f99325e38850ceb29a7b6767475b1175d7f59f9
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like